Mutations and prognosis in primary myelofibrosis

/ Vannucchi, A.M. ; Lasho, T.L. ; Guglielmelli, P. .. — 2013-09

Value of biomarkers in steoarthritis: current status and perspectives

/ Lotz, M. ; Martel-Pelletier, J. ; Christiansen, C. .. — 2013-11-01

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

/ Erben, Philipp ; Schwaab, Juliana ; Metzgeroth, Georgia .. — 2014

KIT mutation analysis in mast cell neoplasms: recommendations of the European competence network on mastocytosis

/ Arock, M. ; Sotlar, K. ; Akin, C. .. — 2015-06

KITD816V andJAK2V617F mutations are seen recurrently in hypereosinophilia of unknown significance

/ Schwaab, Juliana ; Umbach, Roland ; Metzgeroth, Georgia .. — 2015-09

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high risk group of patients with KIT D816V+ advanced systemic mastocytosis

/ Jawhar, M. ; Schwaab, J. ; Schnittger, S. .. — 2016-01

Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients wit...

/ Jawhar, M. ; Schwaab, J. ; Hausmann, D. .. — 2016-12

Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis

/ Naumann, Nicole ; Jawhar, Mohamad ; Schwaab, Juliana .. — 2018-05-01

Inhibitory effects of midostaurin and avapritinib on myeloid progenitors derived from patients with KIT D816V positive advanced systemic mastocytosis

/ Lübke, Johannes ; Naumann, Nicole ; Kluger, Sebastian .. — 2019-05-01

DNA topoisomerase II in therapy-related acute promyelocytic leukemia

/ Mistry, Anita R. ; Felix, Carolyn A. ; Whitmarsh, Ryan J. .. — 2005